Johnson Matthey Plc (JM), a global leader in sustainable technologies, today announces that that it has completed the sale of its Health business in accordance with the terms of the sale agreement entered into between JM and Altaris Capital Partners (“Altaris”), a leading healthcare investment firm.

The Health business, which has been rebranded as Veranova, was sold for a total consideration of £325 million. As part of the transaction, JM will retain approximately a 30% equity stake in Veranova.